Decoding the Possible Molecular Mechanisms in Pediatric Wilms Tumor and Rhabdoid Tumor of the Kidney through Machine Learning Approaches

References

• Tian F, Yourek G, Shi X, Yang Y. The development of Wilms tumor: from WT1 and microRNA to animal models. Biochim Biophys Acta. 2014;1846(1):180–7. doi:10.1016/j.bbcan.2014.07.003.
   PubMed Web of Science ®Google Scholar
• Scott RH, Murray A, Baskcomb L, Turnbull C, Loveday C, Al-Saadi R, Williams R, Breatnach F, Gerrard M, Hale J, et al. Stratification of Wilms tumor by genetic and epigenetic analysis. Oncotarget. 2012;3(3):327–35. doi:10.18632/oncotarget.468.
   PubMedGoogle Scholar
• Deng C, Dai R, Li X, Liu F. Genetic variation frequencies in Wilms’ tumor: a meta-analysis and systematic review. Cancer Sci. 2016;107(5):690–9. doi:10.1111/cas.12910.
   PubMed Web of Science ®Google Scholar
• Hohenstein P, Hastie ND. LINking microRNAs, kidney development, and Wilms tumors. Genes Dev. 2014;28(9):923–5. doi:10.1101/gad.242735.114.
   PubMed Web of Science ®Google Scholar
• Gadd S, Sredni ST, Huang CC, Perlman EJ. Rhabdoid tumor: gene expression clues to pathogenesis and potential therapeutic targets. Lab Invest. 2010;90(5):724–38. doi:10.1038/labinvest.2010.66.
   PubMed Web of Science ®Google Scholar
• Tomlinson GE, Breslow NE, Dome J, Guthrie KA, Norkool P, Li S, Thomas PRM, Perlman E, Beckwith JB, D'Angio GJ, et al. Rhabdoid tumor of the kidney in the National Wilms’ Tumor Study: age at diagnosis as a prognostic factor. J Clin Oncol. 2005;23(30):7641–5. doi:10.1200/jco.2004.00.8110.
   PubMed Web of Science ®Google Scholar
• Chen H, Lu S, Guan J, Zhu X, Sun F, Huang J, Zhu J, Wang J, Zhen Z, Que Y, et al. Identification of prognostic immune-related genes in rhabdoid tumor of kidney based on TARGET database analysis. Aging (Albany NY)). 2021;13(4):5461–74. doi:10.18632/aging.202475.
   PubMedGoogle Scholar
• Ooms A, Vujanić GM, D'Hooghe E, Collini P, L'Herminé-Coulomb A, Vokuhl C, et al. Renal tumors of childhood-a histopathologic pattern-based diagnostic approach. Cancers (Basel). 2020;12(3):729. doi:10.3390/cancers12030729.
   PubMed Web of Science ®Google Scholar
• Institute N-NC. The Cancer Genome Atlas (TCGA). 2021. https://portal.gdc.cancer.gov.
   Google Scholar
• Ferreira AJ, Figueiredo MA. Efficient feature selection filters for high-dimensional data. Pattern Recog Lett. 2012;33(13):1794–804. doi:10.1016/j.patrec.2012.05.019.
   Web of Science ®Google Scholar
• Bommert A, Sun X, Bischl B, Rahnenführer J, Lang M. Benchmark for filter methods for feature selection in high-dimensional classification data. Comput Stat Data Anal. 2020;143:106839. doi:10.1016/j.csda.2019.106839.
   Web of Science ®Google Scholar
• Bakhshandeh S, Azmi R, Teshnehlab M. Symmetric uncertainty class-feature association map for feature selection in microarray dataset. Int J Mach Learn Cyber. 2020;11(1):15–32. doi:10.1007/s13042-019-00932-7.
   Web of Science ®Google Scholar
• Hosseiniyan Khatibi SM, Ardalan M, Teshnehlab M, Vahed SZ, Pirmoradi S. Panels of mRNAs and miRNAs for decoding molecular mechanisms of Renal Cell Carcinoma (RCC) subtypes utilizing Artificial Intelligence approaches. Sci Rep. 2022;12(1):16393. doi:10.1038/s41598-022-20783-7.
   PubMed Web of Science ®Google Scholar
• Blondel VD, Guillaume J-L, Lambiotte R, Lefebvre E. Fast unfolding of communities in large networks. J Stat Mech. 2008; 2008(10):P10008. doi:10.1088/1742-5468/2008/10/P10008.
   Web of Science ®Google Scholar
• Boppana R, Halldórsson MM. Approximating maximum independent sets by excluding subgraphs. BIT Numer Math. 1992;32(2):180–96. doi:10.1007/BF01994876.
   Google Scholar
• Aghayousefi R, Hosseiniyan Khatibi SM, Zununi Vahed S, Bastami M, Pirmoradi S, Teshnehlab M. A diagnostic miRNA panel to detect recurrence of ovarian cancer through artificial intelligence approaches. J Cancer Res Clin Oncol. 2023;149(1):325–41. doi:10.1007/s00432-022-04468-2.
   PubMed Web of Science ®Google Scholar
• Pirmoradi S, Teshnehlab M, Zarghami N, Sharifi A. A self-organizing deep auto-encoder approach for classification of complex diseases using SNP genomics data. Appl Soft Comput. 2020; 97:106718. doi:10.1016/j.asoc.2020.106718.
   Web of Science ®Google Scholar
• Hosseiniyan Khatibi SM, Najjarian F, Homaei Rad H, Ardalan M, Teshnehlab M, Zununi Vahed S, Pirmoradi S. Key therapeutic targets implicated at the early stage of hepatocellular carcinoma identified through machine-learning approaches. Sci Rep. 2023;13(1):3840. doi:10.1038/s41598-023-30720-x.
   PubMed Web of Science ®Google Scholar
• Agrawal R, Srikant R, editors. Fast algorithms for mining association rules. In: Proceedings of the 20th International Conference Very Large Data Bases, VLDB. Citeseer; 1994.
   Google Scholar
• Wach S, Nolte E, Theil A, Stöhr C, T Rau T, Hartmann A, Ekici A, Keck B, Taubert H, Wullich B, et al. MicroRNA profiles classify papillary renal cell carcinoma subtypes. Br J Cancer. 2013;109(3):714–22. doi:10.1038/bjc.2013.313.
   PubMed Web of Science ®Google Scholar
• Youssef YM, White NMA, Grigull J, Krizova A, Samy C, Mejia-Guerrero S, Evans A, Yousef GM. Accurate molecular classification of kidney cancer subtypes using MicroRNA signature. Eur Urol. 2011;59(5):721–30. doi:10.1016/j.eururo.2011.01.004.
   PubMed Web of Science ®Google Scholar
• Muhamed Ali A, Zhuang H, Ibrahim A, Rehman O, Huang M, Wu A. A machine learning approach for the classification of kidney cancer subtypes using miRNA genome data. Appl Sci. 2018;8(12):2422. doi:10.3390/app8122422.
   Google Scholar
• Pirmoradi S, Teshnehlab M, Zarghami N, Sharifi A. A self-organizing deep neuro-fuzzy system approach for classification of kidney cancer subtypes using miRNA genomics data. Comput Methods Programs Biomed. 2021;206:106132. doi:10.1016/j.cmpb.2021.106132.
   PubMed Web of Science ®Google Scholar
• Shukrun R, Pode-Shakked N, Pleniceanu O, Omer D, Vax E, Peer E, Pri-Chen S, Jacob J, Hu Q, Harari-Steinberg O, et al. Wilms’ tumor blastemal stem cells dedifferentiate to ­propagate the tumor bulk. Stem Cell Rep. 2014;3(1):24–33. doi:10.1016/j.stemcr.2014.05.013.
   PubMed Web of Science ®Google Scholar
• Grundy P, Coppes M. An overview of the clinical and molecular genetics of Wilms’ tumor. Med Pediatr Oncol. 1996;27(5):394–7. doi:10.1002/(sici)1096-911x(199611)27:5 < 394::Aid-mpo1 > 3.0.Co;2-h.
   PubMedGoogle Scholar
• Bharathavikru R, Dudnakova T, Aitken S, Slight J, Artibani M, Hohenstein P, Tollervey D, Hastie N. Transcription factor Wilms’ tumor 1 regulates developmental RNAs through 3’ UTR interaction. Genes Dev. 2017;31(4):347–52. doi:10.1101/gad.291500.116.
   PubMed Web of Science ®Google Scholar
• Delgado AP, Brandao P, Chapado MJ, Hamid S, Narayanan R. Open reading frames associated with cancer in the dark matter of the human genome. Cancer Genomics Proteomics. 2014;11(4):201–13.
   PubMed Web of Science ®Google Scholar
• Wang X-R, Zhou Y-B, Liu F, Wang K-S, Shen Y, Liu J-H, Han Z-G. A novel recently evolved gene C19orf24 encodes a non-classical secreted protein. Cell Mol Biol Lett. 2006;11(2):161–70. doi:10.2478/s11658-006-0014-6.
   PubMed Web of Science ®Google Scholar
• Zhang Y, Yu S, Xie R, Li J, Leier A, Marquez-Lago TT, Akutsu T, Smith AI, Ge Z, Wang J, et al. PeNGaRoo, a combined gradient boosting and ensemble learning framework for predicting non-classical secreted proteins. Bioinformatics. 2020;36(3):704–12. doi:10.1093/bioinformatics/btz629.
   PubMed Web of Science ®Google Scholar
• Lu W, Fu D, Kong X, Huang Z, Hwang M, Zhu Y, Chen L, Jiang K, Li X, Wu Y, et al. FOLFOX treatment response prediction in metastatic or recurrent colorectal cancer patients via machine learning algorithms. Cancer Med. 2020;9(4):1419–29. doi:10.1002/cam4.2786.
   PubMed Web of Science ®Google Scholar
• Gadd S, Huff V, Huang C-C, Ruteshouser EC, Dome JS, Grundy PE, Breslow N, Jennings L, Green DM, Beckwith JB, et al. Clinically relevant subsets identified by gene expression patterns support a revised ontogenic model of Wilms tumor: a Children’s Oncology Group Study. Neoplasia. 2012;14(8):742–56. doi:10.1593/neo.12714.
   PubMed Web of Science ®Google Scholar
• McDonald JM, Douglass EC, Fisher R, Geiser CF, Krill CE, Strong LC, et al. Linkage of familial Wilms’ tumor predisposition to chromosome 19 and a two-locus model for the etiology of familial tumors. Cancer Res. 1998;58(7):1387–90.
   PubMed Web of Science ®Google Scholar
• Lichti CF, Liu H, Shavkunov AS, Mostovenko E, Sulman EP, Ezhilarasan R, Wang Q, Kroes RA, Moskal JC, Fenyö D, et al. Integrated chromosome 19 transcriptomic and proteomic data sets derived from glioma cancer stem-cell lines. J Proteome Res. 2014;13(1):191–9. doi:10.1021/pr400786s.
   PubMed Web of Science ®Google Scholar
• Huang M, Chen Y, Han D, Lei Z, Chu X. Role of the zinc finger and SCAN domain-containing transcription factors in cancer. Am J Cancer Res. 2019;9(5):816–36.
   PubMed Web of Science ®Google Scholar
• Wang X-X, Xiao F-H, Li Q-G, Liu J, He Y-H, Kong Q-P. Large-scale DNA methylation expression analysis across 12 solid cancers reveals hypermethylation in the calcium-signaling pathway. Oncotarget. 2017;8(7):11868–76. doi:10.18632/oncotarget.14417.
   PubMedGoogle Scholar
• Zhong X, Zhong G. Prognostic biomarker identification and tumor classification in breast cancer patients by methylation and transcriptome analysis. FEBS Open Bio. 2021;11(8):2139–51. doi:10.1002/2211-5463.13211.
   PubMed Web of Science ®Google Scholar
• Sapkota S, Horiguchi K, Tosaka M, Yamada S, Yamada M. Whole-exome sequencing study of thyrotropin-secreting pituitary adenomas. J Clin Endocrinol Metab. 2017;102(2):566–75. doi:10.1210/jc.2016-2261.
   PubMed Web of Science ®Google Scholar
• Wen Y, Zhou X, Lu M, He M, Tian Y, Liu L, Wang M, Tan W, Deng Y, Yang X, et al. Bclaf1 promotes angiogenesis by regulating HIF-1alpha transcription in hepatocellular carcinoma. Oncogene. 2019;38(11):1845–59. doi:10.1038/s41388-018-0552-1.
   PubMed Web of Science ®Google Scholar
• Horiuchi K, Kawamura T, Iwanari H, Ohashi R, Naito M, Kodama T, Hamakubo T. Identification of Wilms’ tumor 1-associating protein complex and its role in alternative splicing and the cell cycle. J Biol Chem. 2013;288(46):33292–302. doi:10.1074/jbc.M113.500397.
   PubMed Web of Science ®Google Scholar
• Tang J, Wang F, Cheng G, Si S, Sun X, Han J, Yu H, Zhang W, Lv Q, Wei J-F, et al. Wilms’ tumor 1-associating protein promotes renal cell carcinoma proliferation by regulating CDK2 mRNA stability. J Exp Clin Cancer Res. 2018;37(1):40. doi:10.1186/s13046-018-0706-6.
   PubMedGoogle Scholar
• Xie W, Wei L, Guo J, Guo H, Song X, Sheng X. Physiological functions of Wilms’ tumor 1-associating protein and its role in tumourigenesis. J Cell Biochem. 2019;120(7):10884–92. doi:10.1002/jcb.28402.
   PubMed Web of Science ®Google Scholar
• Shao A, Lang Y, Wang M, Qin C, Kuang Y, Mei Y, Lin D, Zhang S, Tang J. Bclaf1 is a direct target of HIF-1 and critically regulates the stability of HIF-1alpha under hypoxia. Oncogene. 2020;39(13):2807–18. doi:10.1038/s41388-020-1185-8.
   PubMed Web of Science ®Google Scholar
• Kitamura E, Cowell JK, Chang CS, Hawthorn L. Variant profiles of genes mapping to chromosome 16q loss in Wilms tumors reveals link to cilia-related genes and pathways. Genes Cancer. 2020;11(3–4):137–53. doi:10.18632/genesandcancer.207.
   PubMedGoogle Scholar
• Fliedner A, Kirchner P, Wiesener A, van de Beek I, Waisfisz Q, van Haelst M, Scott DA, Lalani SR, Rosenfeld JA, Azamian MS, et al. Variants in SCAF4 cause a neurodevelopmental disorder and are associated with impaired mRNA processing. Am J Hum Genet. 2020;107(3):544–54. doi:10.1016/j.ajhg.2020.06.019.
   PubMed Web of Science ®Google Scholar
• Becker R, Loll B, Meinhart A. Snapshots of the RNA processing factor SCAF8 bound to different phosphorylated forms of the carboxyl-terminal domain of RNA polymerase II. J Biol Chem. 2008;283(33):22659–69. doi:10.1074/jbc.M803540200.
   PubMed Web of Science ®Google Scholar
• Gregersen LH, Mitter R, Ugalde AP, Nojima T, Proudfoot NJ, Agami R, Stewart A, Svejstrup JQ. SCAF4 and SCAF8, mRNA anti-terminator proteins. Cell. 2019;177(7):1797–813 e18. doi:10.1016/j.cell.2019.04.038.
   PubMed Web of Science ®Google Scholar
• Gadd S, Huff V, Walz AL, Ooms AHAG, Armstrong AE, Gerhard DS, Smith MA, Auvil JMG, Meerzaman D, Chen Q-R, et al. A Children’s Oncology Group and TARGET initiative exploring the genetic landscape of Wilms tumor. Nat Genet. 2017;49(10):1487–94. doi:10.1038/ng.3940.
   PubMed Web of Science ®Google Scholar
• Nolan ME, Aranda V, Lee S, Lakshmi B, Basu S, Allred DC, Muthuswamy SK. The polarity protein Par6 induces cell proliferation and is overexpressed in breast cancer. Cancer Res. 2008;68(20):8201–9. doi:10.1158/0008-5472.Can-07-6567.
   PubMed Web of Science ®Google Scholar
• Yin X, Wang P, Yang T, Li G, Teng X, Huang W, Yu H. Identification of key modules and genes associated with breast cancer prognosis using WGCNA and ceRNA network analysis. Aging (Albany NY)). 2020;13(2):2519–38. doi:10.18632/aging.202285.
   PubMedGoogle Scholar
• Cunliffe HE, Jiang Y, Fornace KM, Yang F, Meltzer PS. PAR6B is required for tight junction formation and activated PKCζ localization in breast cancer. Am J Cancer Res. 2012;2(5):478–91.
   PubMed Web of Science ®Google Scholar
• Zhou Q, Dai J, Chen T, Dada LA, Zhang X, Zhang W, DeCamp MM, Winn RA, Sznajder JI, Zhou G, et al. Downregulation of PKCζ/Pard3/Pard6b is responsible for lung adenocarcinoma cell EMT and invasion. Cell Signal. 2017;38:49–59. doi:10.1016/j.cellsig.2017.06.016.
   PubMed Web of Science ®Google Scholar
• Li C-F, Liu T-T, Chuang I-C, Chen Y-Y, Fang F-M, Chan T-C, Li W-S, Huang H-Y. PLCB4 copy gain and PLCß4 overexpression in primary gastrointestinal stromal tumors: integrative characterization of a lipid-catabolizing enzyme associated with worse disease-free survival. Oncotarget. 2017;8(12):19997–20010. doi:10.18632/oncotarget.15306.
   PubMedGoogle Scholar
• Wu S, Zhang W, Shen D, Lu J, Zhao L. PLCB4 upregulation is associated with unfavorable prognosis in pediatric acute myeloid leukemia. Oncol Lett. 2019;18(6):6057–65. doi:10.3892/ol.2019.10921.
   PubMed Web of Science ®Google Scholar
• Li K, Wang C, Xiong X, Ma H, Qi Y, Hu W, Xiao S, Zhou X, Pang L, Zou H. Small-cell variant renal oncocytoma: case report on its clinicopathological and genetic characteristics and literature review. Gene. 2020;730:144266. doi:10.1016/j.gene.2019.144266.
   PubMed Web of Science ®Google Scholar
• Hong K, Hu L, Liu X, Simon JM, Ptacek TS, Zheng X, Liao C, Baldwin AS, Zhang Q. USP37 promotes deubiquitination of HIF2α in kidney cancer. Proc Natl Acad Sci U S A. 2020;117(23):13023–32. doi:10.1073/pnas.2002567117.
   PubMed Web of Science ®Google Scholar
• Cai J, Li M, Wang X, Li L, Li Q, Hou Z, Jia H, Liu S. USP37 promotes lung cancer cell migration by stabilizing snail protein via deubiquitination. Front Genet. 2019;10:1324. doi:10.3389/fgene.2019.01324.
   PubMed Web of Science ®Google Scholar
• Pan J, Deng Q, Jiang C, Wang X, Niu T, Li H, Chen T, Jin J, Pan W, Cai X, et al. USP37 directly deubiquitinates and stabilizes c-Myc in lung cancer. Oncogene. 2015;34(30):3957–67. doi:10.1038/onc.2014.327.
   PubMed Web of Science ®Google Scholar
• Wu L, Zhao N, Zhou Z, Chen J, Han S, Zhang X, Bao H, Yuan W, Shu X. PLAGL2 promotes the proliferation and migration of gastric cancer cells via USP37-mediated deubiquitination of Snail1. Theranostics. 2021;11(2):700–14. doi:10.7150/thno.47800.
   PubMed Web of Science ®Google Scholar